Literature DB >> 30117031

Comparison of the association of predicted fat mass, body mass index, and other obesity indicators with type 2 diabetes risk: two large prospective studies in US men and women.

Dong Hoon Lee1, NaNa Keum1,2, Frank B Hu1,3,4, E John Orav5,6, Eric B Rimm1,3,4, Walter C Willett1,3,4, Edward L Giovannucci7,8,9.   

Abstract

Obesity, defined by body mass index (BMI), is a well-established risk factor of type 2 diabetes, but BMI has been criticized for its inability to discriminate fat mass and lean body mass. We examined the association between predicted fat mass and type 2 diabetes risk in two large US prospective cohorts, and compared the magnitude of the association with BMI and other obesity indicators. Validated anthropometric prediction equations previously developed from the National Health and Nutrition Examination Survey were used to estimate predicted fat mass and percent fat for 97,111 participants from the Health Professionals Follow-up Study (1987-2012) and the Nurses' Health Study (1986-2012) who were followed up for type 2 diabetes. Multivariable-adjusted hazard ratios for type 2 diabetes across quintiles of predicted fat mass were 1.00, 1.96, 2.96, 3.90, and 8.38 for men and 1.00, 2.20, 3.50, 5.73, and 12.1 for women; of BMI were 1.00, 1.69, 2.45, 3.54, and 6.94 for men and 1.00, 1.76, 2.86, 4.88, and 9.88 for women. Predicted FM showed the strongest association with type 2 diabetes in men followed by waist circumference (WC), waist-to-height ratio (WHtR), predicted percent fat, BMI, Waist-to-hip ratio (WHR), and a body shape index (ABSI). For women, the strongest association was shown for WHtR, followed by WC, predicted percent fat, predicted fat mass, BMI, ABSI, and WHR. Compared to BMI, predicted fat mass demonstrated consistently stronger association with type 2 diabetes risk. However, there was inconclusive evidence to suggest that predicted fat mass is substantially superior to other obesity indicators.

Entities:  

Keywords:  Anthropometric measure; Body composition; Body mass index; Diabetes; Fat mass; Lean body mass

Mesh:

Year:  2018        PMID: 30117031     DOI: 10.1007/s10654-018-0433-5

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  30 in total

1.  Global healthcare expenditure on diabetes for 2010 and 2030.

Authors:  Ping Zhang; Xinzhi Zhang; Jonathan Brown; Dorte Vistisen; Richard Sicree; Jonathan Shaw; Gregory Nichols
Journal:  Diabetes Res Clin Pract       Date:  2010-02-19       Impact factor: 5.602

Review 2.  Is the association of type II diabetes with waist circumference or waist-to-hip ratio stronger than that with body mass index?

Authors:  Q Qiao; R Nyamdorj
Journal:  Eur J Clin Nutr       Date:  2009-09-02       Impact factor: 4.016

Review 3.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

4.  Effectiveness of A Body Shape Index (ABSI) in predicting chronic diseases and mortality: a systematic review and meta-analysis.

Authors:  M Ji; S Zhang; R An
Journal:  Obes Rev       Date:  2018-01-19       Impact factor: 9.213

Review 5.  Long-term complications of diabetes mellitus.

Authors:  D M Nathan
Journal:  N Engl J Med       Date:  1993-06-10       Impact factor: 91.245

6.  Various adiposity measures show similar positive associations with type 2 diabetes in Caucasians, native Hawaiians, and Japanese Americans: the multiethnic cohort.

Authors:  Astrid Steinbrecher; Sreang Heak; Yukiko Morimoto; Andrew Grandinetti; Larry N Kolonel; Gertraud Maskarinec
Journal:  Asia Pac J Public Health       Date:  2012-04-11       Impact factor: 1.399

Review 7.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis.

Authors:  Eric L Ding; Yiqing Song; Vasanti S Malik; Simin Liu
Journal:  JAMA       Date:  2006-03-15       Impact factor: 56.272

Review 8.  Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots.

Authors:  Samantha Hocking; Dorit Samocha-Bonet; Kerry-Lee Milner; Jerry R Greenfield; Donald J Chisholm
Journal:  Endocr Rev       Date:  2013-04-02       Impact factor: 19.871

9.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

Review 10.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

View more
  37 in total

1.  [Effect of glucagon-like peptide 1 receptor agonists on body fat redistribution and muscle mass in overweight and obese type 2 diabetic patients].

Authors:  Yudan Zhang; Shiqun Liu; Cunxia Fan; Yanmei Zeng; Jimin Li; Cuihua Xie; Yaoming Xue; Meiping Guan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-04-30

2.  Circulating Biomarker Score for Visceral Fat and Risks of Incident Colorectal and Postmenopausal Breast Cancer: The Multiethnic Cohort Adiposity Phenotype Study.

Authors:  Loïc Le Marchand; Lynne R Wilkens; Ann M Castelfranco; Kristine R Monroe; Bruce S Kristal; Iona Cheng; Gertraud Maskarinec; Meredith A Hullar; Johanna W Lampe; John A Shepherd; Adrian Franke; Thomas Ernst; Unhee Lim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-03-04       Impact factor: 4.254

3.  Long-term status of predicted body fat percentage, body mass index and other anthropometric factors with risk of colorectal carcinoma: Two large prospective cohort studies in the US.

Authors:  Akiko Hanyuda; Dong Hoon Lee; Shuji Ogino; Kana Wu; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2019-07-23       Impact factor: 7.396

4.  Associations of body shape index (ABSI) and hip index with liver, metabolic, and inflammatory biomarkers in the UK Biobank cohort.

Authors:  Sofia Christakoudi; Elio Riboli; Evangelos Evangelou; Konstantinos K Tsilidis
Journal:  Sci Rep       Date:  2022-05-25       Impact factor: 4.996

5.  Discovering Engagement Personas in a Digital Diabetes Prevention Program.

Authors:  Jonathan H Hori; Elizabeth X Sia; Kimberly G Lockwood; Lisa A Auster-Gussman; Sharon Rapoport; OraLee H Branch; Sarah A Graham
Journal:  Behav Sci (Basel)       Date:  2022-05-24

6.  Predicted lean body mass, fat mass and risk of lung cancer: prospective US cohort study.

Authors:  Su-Min Jeong; Dong Hoon Lee; Edward L Giovannucci
Journal:  Eur J Epidemiol       Date:  2019-11-21       Impact factor: 8.082

7.  The perils of using predicted values in place of observed covariates: an example of predicted values of body composition and mortality risk.

Authors:  Gregory Haber; Joshua Sampson; Katherine M Flegal; Barry Graubard
Journal:  Am J Clin Nutr       Date:  2021-08-02       Impact factor: 7.045

8.  Comparison of anthropometric and body composition indices in the identification of metabolic risk factors.

Authors:  Bum Ju Lee; Mi Hong Yim
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

9.  Genetically predicted body composition in relation to cardiometabolic traits: a Mendelian randomization study.

Authors:  Hailuan Zeng; Chenhao Lin; Sijia Wang; Yan Zheng; Xin Gao
Journal:  Eur J Epidemiol       Date:  2021-06-30       Impact factor: 8.082

10.  Evolution of Postpartum Weight and Body Composition after Excessive Gestational Weight Gain: The Role of Lifestyle Behaviors-Data from the INTER-ACT Control Group.

Authors:  Margriet Bijlholt; Lieveke Ameye; Hanne van Uytsel; Roland Devlieger; Annick Bogaerts
Journal:  Int J Environ Res Public Health       Date:  2021-06-11       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.